EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Palbociclib releases the latent differentiation capacity of neuroblastoma cells

Kirsty M Ferguson, Sarah L Gillen, Lewis Chaytor, Evon Poon, Daniel Marcos, Roshna Lawrence Gomez, Laura M Woods, Lidiya Mykhaylechko, Louis Elfari, Barbara Martins da Costa, Yann Jamin, Jason S Carroll und 3 weitere

Developmental Cell · 2023-10 · 58 (19) · 1967-1982.e8

DOI: 10.1016/j.devcel.2023.08.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Developmental Cell, 2023-10. Verfasst von Kirsty M Ferguson und 14 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK. Hauptthemen laut MEDLINE: Tretinoin, Neuroblastoma, Piperazines, Pyridines. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Wellcome Trust, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroblastoma is the most common extracranial solid tumor in infants, arising from developmentally stalled neural crest-derived cells. Driving tumor differentiation is a promising therapeutic approach for this devastating disease. Here, we show that the CDK4/6 inhibitor palbociclib not only inhibits proliferation but induces extensive neuronal differentiation of adrenergic neuroblastoma cells. Palbociclib-mediated differentiation is manifested by extensive phenotypic and transcriptional changes accompanied by the establishment of an epigenetic program driving expression of mature neuronal features. In vivo palbociclib significantly inhibits tumor growth in mouse neuroblastoma models. Furthermore, dual treatment with retinoic acid resets the oncogenic adrenergic core regulatory circuit of neuroblastoma cells, further suppresses proliferation, and can enhance differentiation, altering gene expression in ways that significantly correlate with improved patient survival. We therefore identify palbociclib as a therapeutic approach to dramatically enhance neuroblastoma differentiation efficacy that could be used in combination with retinoic acid to improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TretinoinNeuroblastomaPiperazinesPyridinesAnimalsMiceHumansCell Line, TumorCell DifferentiationAdrenergic Agents

Stichwörter der Autor:innen

CDK4CDK6cell cycledifferentiationneuroblastomapalbociclibretinoic acid

Substanzen

palbociclibTretinoinAdrenergic AgentsPiperazinesPyridines

Autor:innen und Institutionen

  • Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK.
  • Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK; Department of Oncology, University of Cambridge, Cambridge CB2 0XZ, UK.
  • Division of Clinical Studies, The Institute of Cancer Research (ICR) and Royal Marsden NHS Trust, Sutton SM2 5NG, UK.
  • College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Healthcare City, P.O. Box 505055, Dubai, United Arab Emirates.
  • Wellcome-MRC Cambridge Stem Cell Institute Advanced Imaging Facility, Cambridge CB2 0AW, UK.
  • Division of Radiotherapy and Imaging, The Institute of Cancer Research (ICR) and Royal Marsden NHS Trust, Sutton SM2 5NG, UK.

Förderung

  • Cancer Research UK
  • Wellcome Trust
  • Medical Research Council
  • UK Research and Innovation
  • UKRI Medical Research Council
  • Institute of Cancer Research
  • MBRU
  • Cancer Research UK Cambridge Institute, University of Cambridge

Zitieren

APA

Ferguson, K. M., Gillen, S. L., Chaytor, L., Poon, E., Marcos, D., Gomez, R. L., Woods, L. M., Mykhaylechko, L., Elfari, L., Martins da Costa, B., Jamin, Y., Carroll, J. S., Chesler, L., Ali, F. R., & Philpott, A. (2023). Palbociclib releases the latent differentiation capacity of neuroblastoma cells. Developmental Cell, 58(19), 1967-1982.e8. https://doi.org/10.1016/j.devcel.2023.08.028

Vancouver

Ferguson KM, Gillen SL, Chaytor L, Poon E, Marcos D, Gomez RL, et al. Palbociclib releases the latent differentiation capacity of neuroblastoma cells. Developmental Cell. 2023;58(19):1967-1982.e8. doi:10.1016/j.devcel.2023.08.028

BibTeX
@article{Ferguson2023,
  author = {Ferguson, Kirsty M and Gillen, Sarah L and Chaytor, Lewis and Poon, Evon and Marcos, Daniel and Gomez, Roshna Lawrence and Woods, Laura M and Mykhaylechko, Lidiya and Elfari, Louis and Martins da Costa, Barbara and Jamin, Yann and Carroll, Jason S and Chesler, Louis and Ali, Fahad R and Philpott, Anna},
  title = {Palbociclib releases the latent differentiation capacity of neuroblastoma cells},
  journal = {Developmental Cell},
  year = {2023},
  volume = {58},
  number = {19},
  pages = {1967--1982.e8},
  doi = {10.1016/j.devcel.2023.08.028}
}
Kostenlos starten →